Skip to main content
Retour
Watch Compare

Climb Bio, Inc.

Qualité des données : 83%
CLYM
Nasdaq Manufacturing Chemicals
7,78 €
▲ 0,68 € (9,58%)
Cap. Boursière: 530,47 M
Prix
7,78 €
Cap. Boursière
530,47 M
Fourchette du Jour
7,09 € — 7,89 €
Fourchette 52 Semaines
1,09 € — 8,04 €
Volume
365 233
Ouverture 7,09 €
Moyenne 50J / 200J
6,26 €
24,30% above
Moyenne 50J / 200J
3,27 €
137,72% above

Quick Summary

Points Clés

Negative free cash flow of -54,54 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-33,00%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC-29,50%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio18,38
Interest CoverageN/A

Valorisation

PE (TTM)
-8,86
En dessous de la moyenne du secteur (-1,47)
P/B Ratio3,00
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -8,9 -1,5
P/B 3,0 1,6
ROE % -33,0 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

ETFs Holding This Stock

BRUSX BRUSX
0,22% weight
BRSIX BRSIX
0,15% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -59,85 M
ROE -33,00% ROA -31,95%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -54,54 M
ROIC -29,50% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 18,38
Interest Coverage N/A Asset Turnover N/A
Working Capital 86,02 M Tangible Book Value 177,00 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -8,86 Forward P/E N/A
P/B Ratio 3,00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -10,28%
Market Cap 530,47 M Enterprise Value 504,67 M
Per Share
EPS (Diluted TTM) -0,88 Revenue / Share N/A
FCF / Share -0,80 OCF / Share -0,80
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 91,13%
SBC-Adj. FCF -64,48 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -59,85 M -73,90 M -35,12 M -45,24 M -47,48 M
EPS (Diluted) -0,88 -1,53 -1,30 -1,72 —
Gross Profit — — — — —
Operating Income -67,88 M -82,02 M -40,28 M -45,14 M -35,67 M
EBITDA — — — — —
R&D Expenses 46,71 M 14,18 M 15,41 M 26,21 M 22,05 M
SG&A Expenses — — — — —
D&A 97 000,0 — — — —
Interest Expense — — — — —
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 167,74 M 217,19 M 110,47 M 134,99 M 173,24 M
Total Liabilities 7,27 M 5,31 M 2,87 M 6,28 M 6,04 M
Shareholders' Equity 160,48 M 211,88 M 107,60 M 128,72 M 167,20 M
Total Debt — — — — —
Cash & Equivalents 35,69 M 87,23 M 93,11 M 43,59 M 46,92 M
Current Assets 105,85 M 154,87 M 110,26 M 134,39 M 148,25 M
Current Liabilities 6,98 M 4,93 M 2,83 M 6,10 M 6,03 M